Ningshao Xia

Research interests

Publications

• A nanovaccine for antigen self-presentation and immunosuppression reversal as a personalized cancer immunotherapy strategy

  Nature Nanotechnology · 2022 · https://doi.org/10.1038/s41565-022-01098-0

• Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collaborative pooled analysis of 64 studies

  The Lancet HIV · 2021 · https://doi.org/10.1016/s2352-3018(21)00108-9

• Methods Favoring Homology-Directed Repair Choice in Response to CRISPR/Cas9 Induced-Double Strand Breaks

  International Journal of Molecular Sciences · 2020 · https://doi.org/10.3390/ijms21186461

• Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset

  European Respiratory Journal · 2020 · https://doi.org/10.1183/13993003.00763-2020

• Recent Progress on the Versatility of Virus-Like Particles

  Vaccines · 2020 · https://doi.org/10.3390/vaccines8010139

• Antibody Responses to SARS-CoV-2 in Patients of Novel Coronavirus Disease 2019

  SSRN Electronic Journal · 2020 · https://doi.org/10.2139/ssrn.3546052

• Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019

  Clinical Infectious Diseases · 2020 · https://doi.org/10.1093/cid/ciaa344

• Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019

  medRxiv · 2020 · https://doi.org/10.1101/2020.03.02.20030189

• Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial

  JNCI Journal of the National Cancer Institute · 2019 · https://doi.org/10.1093/jnci/djz074

• Rat Hepatitis E Virus as Cause of Persistent Hepatitis after Liver Transplant

  Emerging infectious diseases · 2018 · https://doi.org/10.3201/eid2412.180937

• Origin, antigenicity, and function of a secreted form of ORF2 in hepatitis E virus infection

  Proceedings of the National Academy of Sciences · 2018 · https://doi.org/10.1073/pnas.1721345115

• LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration

  Nature · 2018 · https://doi.org/10.1038/s41586-018-0615-z

• Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration

  Science Translational Medicine · 2016 · https://doi.org/10.1126/scitranslmed.aaf2304

• Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound

  Journal of Hepatology · 2016 · https://doi.org/10.1016/j.jhep.2016.05.029

• Long-Term Efficacy of a Hepatitis E Vaccine

  New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1406011

• Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

  Science · 2013 · https://doi.org/10.1126/science.1243283

• Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

  Science · 2013 · https://doi.org/10.1126/science.1234914

• Virus-like particle-based human vaccines: quality assessment based on structural and functional properties

  Trends in biotechnology · 2013 · https://doi.org/10.1016/j.tibtech.2013.09.002

• Hepatitis E

  The Lancet · 2012 · https://doi.org/10.1016/s0140-6736(11)61849-7

• Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors

  Journal of Hepatology · 2012 · https://doi.org/10.1016/j.jhep.2012.05.009

• Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial

  The Lancet · 2010 · https://doi.org/10.1016/s0140-6736(10)61030-6

• Establishment of multiple sublineages of H5N1 influenza virus in Asia: Implications for pandemic control

  Proceedings of the National Academy of Sciences · 2006 · https://doi.org/10.1073/pnas.0511120103

• A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates

  Vaccine · 2004 · https://doi.org/10.1016/j.vaccine.2004.11.064

Current projects

No projects listed.